Home/Filings/4/0000908834-25-000358
4//SEC Filing

EW HEALTHCARE PARTNERS FUND 2-A, L.P. 4

Accession 0000908834-25-000358

CIK 0001561921other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 4:26 PM ET

Size

11.8 KB

Accession

0000908834-25-000358

Insider Transaction Report

Form 4
Period: 2025-11-17
Transactions
  • Purchase

    Common Stock, par value $0.001 per share

    2025-11-17$1.11/sh+3,604,000$4,000,4407,714,709 total
Transactions
  • Purchase

    Common Stock, par value $0.001 per share

    2025-11-17$1.11/sh+3,604,000$4,000,4407,714,709 total
Transactions
  • Purchase

    Common Stock, par value $0.001 per share

    2025-11-17$1.11/sh+3,604,000$4,000,4407,714,709 total
Transactions
  • Purchase

    Common Stock, par value $0.001 per share

    2025-11-17$1.11/sh+3,604,000$4,000,4407,714,709 total
Footnotes (1)
  • [F1]Shares of the Issuer's common stock acquired in the Issuer's underwritten registered direct offering at a price of $1.11 per share. Consists of 1,416,249 shares acquired by EW Healthcare Partners Fund 2, L.P. and 2,187,751 shares acquired by EW Healthcare Partners Fund 2-A, L.P.

Documents

1 file

Issuer

TELA Bio, Inc.

CIK 0001561921

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001746779

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:26 PM ET
Size
11.8 KB